[go: up one dir, main page]

AU1123497A - Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome - Google Patents

Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome

Info

Publication number
AU1123497A
AU1123497A AU11234/97A AU1123497A AU1123497A AU 1123497 A AU1123497 A AU 1123497A AU 11234/97 A AU11234/97 A AU 11234/97A AU 1123497 A AU1123497 A AU 1123497A AU 1123497 A AU1123497 A AU 1123497A
Authority
AU
Australia
Prior art keywords
immune deficiency
deficiency syndrome
acquired immune
packaging cells
recombinant hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11234/97A
Inventor
Nickolas Chelyapov
Syed Zaki Salahuddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clinical Technology Inc
Original Assignee
Clinical Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/563,360 external-priority patent/US6063374A/en
Priority claimed from US08/563,597 external-priority patent/US5753490A/en
Application filed by Clinical Technology Inc filed Critical Clinical Technology Inc
Publication of AU1123497A publication Critical patent/AU1123497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16041Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11234/97A 1995-11-28 1996-11-25 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome Abandoned AU1123497A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/563,360 US6063374A (en) 1995-11-28 1995-11-28 Recombinant HIV and modified packaging cells and method for using
US563360 1995-11-28
US563597 1995-11-28
US08/563,597 US5753490A (en) 1995-11-28 1995-11-28 Recombinant HIV and modified packaging cells and method for treating acquired immune deficiency syndrome
PCT/US1996/018885 WO1997020052A1 (en) 1995-11-28 1996-11-25 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome

Publications (1)

Publication Number Publication Date
AU1123497A true AU1123497A (en) 1997-06-19

Family

ID=27073263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11234/97A Abandoned AU1123497A (en) 1995-11-28 1996-11-25 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome

Country Status (3)

Country Link
EP (1) EP0863988A1 (en)
AU (1) AU1123497A (en)
WO (1) WO1997020052A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004026A2 (en) * 1997-07-18 1999-01-28 Chiron Corporation Lentiviral vectors
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
JP2002508338A (en) * 1997-12-12 2002-03-19 ナルディニ,ルイジ Therapeutic use of lentiviral vectors
ATE368122T1 (en) 1999-04-29 2007-08-15 Cell Genesys Inc METHOD AND MEANS FOR PRODUCING SAFE HIGH TITRE RECOMBINANT LENTIVIRAL VECTORS
CN109810953A (en) * 2019-01-07 2019-05-28 西安彤盛生物科技有限公司 The recombination the Temple of Heaven strain oncolytic vaccinia virus of removal TK gene and its preparation and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306631A (en) * 1987-08-21 1994-04-26 University Of Colorado Foundation, Inc. Compositions and method for inhibition of HIV production
US5206353A (en) * 1988-07-23 1993-04-27 The United States Of America As Represented By The Department Of Health And Human Services CD-4/cytotoxic gene fusions

Also Published As

Publication number Publication date
WO1997020052A1 (en) 1997-06-05
EP0863988A1 (en) 1998-09-16

Similar Documents

Publication Publication Date Title
AU1074997A (en) Controlled atmosphere package
AU2366895A (en) Method for heat-treating wood and wood products
AU696741B2 (en) Packages and their manufacturing process
AU8153594A (en) Device and method for palletizing unstable articles
AU6344794A (en) Consolidatable particulate material and well treatment method
AU5052093A (en) Laminating method and products made thereby
EP0808274A4 (en) Opening and lowering cartons onto article groups
AU2040695A (en) Method and system for inspecting packages
AU1131995A (en) Conveyor system for divergence and convergence
AU4305197A (en) Method and apparatus for packaging flat articles
AU4277789A (en) Packaging method and apparatus
AU7767794A (en) Packages and their manufacture
AU6364790A (en) Packaging machine and method
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU7795191A (en) Vapor clarification system and method
AU4508689A (en) Recombinant pdgf and methods for production
EP0728678A3 (en) Microwaveable food package, and method for manufacturing same
AU1123497A (en) Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome
AU4641096A (en) Paperboard package and method for forming same
HUP9700074A3 (en) Low molecular yeast active substance extract and process for preparing the same
GB9304521D0 (en) Improved alumoxane,method for its preparation and polymerisation process using such alumoxane
AU7059498A (en) Aseptic packaging process and apparatus
AU6060694A (en) Method for treating acquired immune deficiency syndrome
AU2172097A (en) Infusion packages and methods for their manufacture
AU8968598A (en) Bovine footrot treatment and prevention